News on this topic
Early Data Indicates an A.I.-Generated Drug Could Slow Aging: Artificial intelligence was used to help develop a drug candidate, rentosertib ...
nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
Similar to This
Citrini Research is backing life sciences stocks after using Claude to design proteins
qz.com/citrini-research-life-sciences-stocks-claude-protein-design-102026
Citrini Research is backing life sciences stocks after using Claude to ...
AstraZeneca is partnering with AI biotech insitro in a deal worth up to $1.5 billion
qz.com/astrazeneca-insitro-ai-drug-discovery-deal-101626
AstraZeneca is partnering with AI biotech insitro in a deal worth up to $1 ...
Iambic Therapeutics stock rises 16% in Nasdaq debut after IPO
dlvr.it/TVy16K
Iambic Therapeutics stock rises 16% in Nasdaq debut after IPO
‘AI lowers the capital needed’: India’s drug discovery push faces test of human trials
channelnewsasia.com/asia/ai-lowers-capital-needed-indias-drug-discovery-push-faces-test-human-trials-6462176
‘AI lowers the capital needed’: India’s drug discovery push faces test of ...
Control theory of aging and longevity for gerotherapeutic drug discovery: state space, vector fields, modalities, safety, and the minimum safe cost of ...
doi.org/10.18632/aging.206422
Control theory of aging and longevity for gerotherapeutic drug discovery: ...
Crossed Wires: There is a nobler side to the AI hype: While AI’s risks dominate headlines, its quieter revolution in drug discovery is producing new treatments ...
dailymaverick.co.za/article/2026-09-27-cossed-wires-there-is-a-nobler-side-to-the-ai-hype/
Crossed Wires: There is a nobler side to the AI hype
AI may have cracked the antiaging code: A pharmaceutical company called Insilico Medicine believes that the drug they discovered using AI could be the key to ...
theweek.com/health/ai-anti-aging-drug-insilico-rentosertib
AI may have cracked the antiaging code
New MS treatment 'within reach' after existing drug discovery: More than 150,000 people live with MS in the UK
getsurrey.co.uk/news/uk-world-news/new-ms-treatment-within-reach-34628956
New MS treatment 'within reach' after existing drug discovery
AI may have cracked the antiaging code: A pharmaceutical company called Insilico Medicine believes that the drug they discovered using AI could be the key to ...
theweek.com/health/ai-anti-aging-drug-insilico-rentosertib
AI may have cracked the antiaging code
Can a Drug to Treat Lung Disease Slow Biological Aging? A 12-Week Trial Found Early Signs
inc.com/lucia-auerbach/can-drug-treat-lung-disease-slow-biological-aging-12-week-trial-found-early-signs/91402885
Can a Drug to Treat Lung Disease Slow Biological Aging? A 12-Week Trial ...
AI-designed drug candidate reverses biological age in clinical study: Insilico Medicine ("Insilico"), a clinical-stage company focused on generative ...
news-medical.net/news/20260907/AI-designed-drug-candidate-reverses-biological-age-in-clinical-study.aspx
AI-designed drug candidate reverses biological age in clinical study
Weight-loss drug slows ageing in female mice: In one inbred strain of laboratory mice, late-life treatment with a GLP-1 drug extends lifespan ...
nature.com/articles/d41586-026-02468-7
Weight-loss drug slows ageing in female mice
Takeda and Insilico strike AI-led drug discovery deal worth up to $600m: HONG KONG -- Japanese pharmaceutical giant Takeda has reached a deal with Hong ...
asia.nikkei.com/business/pharmaceuticals/takeda-and-insilico-strike-ai-led-drug-discovery-deal-worth-up-to-600m
Takeda and Insilico strike AI-led drug discovery deal worth up to $600m